Reporting by Asif Shahzad; Editing by John Stonestreet and Alex RichardsonOur Standards: The Thomson Reuters Trust Principles. Reporting by Asif Shahzad Editing by Raissa KasolowskyOur Standards: The Thomson Reuters Trust Principles. "We've acquired technology and expertise to ensure quality control," he said. China's Sinopharm, AstraZeneca and Russia's Sputnik V have also received authorisation. Picture taken June 3, 2021.
Owners of multi-assets have rights different to those of other (mass) beings.
( z0 right :ARG1 ( z1 person :ARG0-of ( z2 own :ARG1 ( z3 asset :quant ( z4 multiple ) ) ) ) :ARG1-of ( z5 differ :ARG2 ( z6 right :ARG1 ( z7 being :mod ( z8 mass ) :mod ( z9 other ) ) ) ) )
(z0 / right-05
    :ARG1 (z1 / person
              :ARG0-of (z2 / own-01
                           :ARG1 (z3 / asset
                                     :quant (z4 / multiple))))
    :ARG1-of (z5 / differ-02
                 :ARG2 (z6 / right-05
                           :ARG1 (z7 / being
                                     :mod (z8 / mass)
                                     :mod (z9 / other)))))
Owners of multi - assets have rights different to those of other ( mass ) beings .
z1 :ARG0-of z2
z3 :quant z4
z2 :ARG1 z3
z0 :ARG1 z1
z5 :ARG2 z6
z0 :ARG1-of z5
z7 :mod z8
z7 :mod z9
z6 :ARG1 z7